Brief: EU Validates Enhertu Application for Previously Treated HER2-Positive Solid Tumors
11/09/2025 07:37
Sept 11 (Reuters) - Daiichi Sankyo Co Ltd 4568.T: ENHERTU® TYPE II VARIATION APPLICATION VALIDATED IN THE EU FOR PREVIOUSLY TREATED PATIENTS WITH HER2 POSITIVE METASTATIC SOLID TUMORS DAIICHI SANKYO- VALIDATION CONFIRMS APPLICATION COMPLETION, STARTS SCIENTIFIC REVIEW PROCESS BY EMA'S COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE DAIICHI SANKYO CO LTD - EMA SCIENTIFIC REVIEW PROCESS COMMENCES FOR ENHERTU APPLICATION Source text: ID:nBw98P70Da Further company coverage: 4568.T ((Reuters.Briefs@thomsonreuters.com;))